Print the page
Increase font size
One Thing AI Can’t Do

One Thing AI Can’t Do

Chris Campbell

Posted August 30, 2024

Chris Campbell

This year, I’ve become a bit of a mead maniac—obsessed with brewing the perfect batch.

Making mead is like stepping back in time.

It's an ancient art, a ritual that’s been passed down through generations.

You start with simple ingredients: honey, water, and yeast. Maybe you get a little creative and add herbs.

(The Celts used heather flowers in their mead for its medicinal properties. The Vikings used meadowsweet. The Greeks? Hyssop. The list goes on.)

But the magic happens in the wait.

Mead is a slow brew.

We’re talking months, sometimes even years. You don’t rush it because you can’t. You let nature do its thing, allowing the flavors to evolve, deepen, and mature.

This deliberate process is part of what makes mead so special.

It’s what gives mead its character, its soul.

But let’s be real—few things in life need to take this long.

Some things, like saving lives, don’t get better by hiding them in a dark closet and waiting. They demand speed, precision, and urgency.

Unlike mead, which SHOULD take time, discovering and developing life-saving drugs is an area where speed matters—a lot.

Every day, every week shaved off the drug discovery process can mean the difference between life and death for countless people.

For decades, drug discovery has been this slow, grueling process.

You had scientists in lab coats hunched over microscopes, trying to figure out which molecules might, just might, be the magic bullet for some disease.

It took years, sometimes decades, and billions of dollars.

And even then, more than half of those drugs didn’t make it past the first phase of trials.

But now, AI is stepping into the ring…

The AI Drug Rush

And it’s not just frolicking in the fringes—it’s beginning to dominate. The mainstream media isn’t reporting on it, but it’s happening.

We’re talking about a leap from a 63% success rate in Phase 1 trials to a mind-blowing 80-90% success rate.

Our colleague Ray Blanco calls it the “AI Drug Rush.”

And this is the kind of rush that only comes around once in a generation.

Our main beat here in ALC: It pays to be optimistic.

Well, This is Awkward (Bitcoin!!!)

Posted December 05, 2024

By Chris Campbell

Bitcoin’s $100K breakout is a BIG DEAL for the crypto markets. Here’s what happens next.

Bitcoin Shakeout! (Warning)

Posted December 04, 2024

By Chris Campbell

Moral: When everyone's scared, look at what the smart money is actually doing, not what they're saying.

Better Than Sexy

Posted December 03, 2024

By James Altucher

This might be the most valuable skill you can learn. It's not sexy, it won't make headlines, but it WORKS.

The $5.5 Billion Blindside

Posted December 02, 2024

By Chris Campbell

While most investors chase complexity, they're missing the simple pattern doing cartwheels across their screens.

Wall Street Legend Buys AI Stock (Not NVDA)

Posted December 02, 2024

By Davis Wilson

I Disagree

Thank You For Your Emails

Posted November 30, 2024

By Davis Wilson

Nvidia Price Target — Explained